Nutex Health Inc
Exchange: NASDAQSector: HealthcareIndustry: Health Information Services
Headquartered in Houston, Texas and founded in 2011, Nutex Health Inc. is a healthcare management and operations company with two divisions: a Hospital Division and a Population Health Management Division. The Hospital Division owns, develops and operates innovative health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments. This division owns and operates 27 hospital facilities in 12 states. The Population Health Management division owns and operates provider networks such as Independent Physician Associations. Through our Management Services Organization, we provide management, administrative and other support services to our affiliated hospitals and physician groups.
Did you know?
NUTX's revenue grew at a 26.1% CAGR over the last 5 years.
Current Price
$139.57
+17.09%GoodMoat Value
$748.17
436.1% undervaluedProfile
Valuation (TTM)
Market Cap$972.57M
P/E10.09
EV—
P/B2.95
Shares Out6.97M
P/Sales1.11
Revenue$879.95M
EV/EBITDA5.67
Nutex Health Inc (NUTX) Stock Analysis
Market Cap$972.57M
Current Price$139.57
P/E Ratio10.09
Forward P/E—
PEG Ratio0.13
EPS$10.48
Book Value$47.28
P/B Ratio2.95
NUTX Financial Charts
FCF vs CAPEX
FCFCAPEX
Forward estimates use 50.0% FCF growth (CAGR)
Cash vs Debt
Net Debt: 166M
Revenue
274M
FY20
332M
FY21
219M
FY22
248M
FY23
480M
FY24
875M
FY25
Net Income
106M
FY20
133M
FY21
—
FY22
—
FY23
52M
FY24
71M
FY25
NUTX 52-Week Range
$80.92
$190.49
50-Day MA: $102.98200-Day MA: $116.55
Did you know?
NUTX's revenue grew at a 26.1% CAGR over the last 5 years.
Nutex Health Inc (NUTX) Financial Summary
Nutex Health Inc (NUTX) is a Healthcare company in the Health Information Services industry, listed on NASDAQ. The stock currently trades at $139.57 with a market capitalization of $972.57M.
Key valuation metrics include a P/E ratio of 10.09, price-to-book ratio of 2.95, and EPS of $10.48. The company reports a profit margin of 11.0% and return on equity of 29.3%.
NUTX Key Financial Metrics
| Metric | Value |
|---|---|
| Market Cap | $972.57M |
| P/E Ratio | 10.09 |
| EPS | $10.48 |
| P/B Ratio | 2.95 |
| P/S Ratio | 1.11 |
| EV/EBITDA | 5.67 |
| Profit Margin | 11.0% |
| Return on Equity | 29.3% |
| Debt/Equity | 1.07 |
NUTX Revenue & Earnings History
| Year | Revenue | Net Income |
|---|---|---|
| FY20 | $274.03M | $105.97M |
| FY21 | $331.53M | $132.59M |
| FY22 | $219.29M | $-424.78M |
| FY23 | $247.65M | $-45.79M |
| FY24 | $479.95M | $52.10M |
| FY25 | $875.26M | $70.79M |
Nutex Health Inc (NUTX) Valuation
Based on GoodMoat's DCF model, Nutex Health Inc has a fair value estimate of $748.17. At the current price of $139.57, the stock appears 81.3% undervalued relative to our intrinsic value estimate.
NUTX Quality Indicators
Nutex Health Inc maintains a profit margin of 11.0% and an operating margin of 31.5%. Return on equity stands at 29.3%. The current ratio is 3.41. Debt-to-equity ratio is 1.07.
About Nutex Health Inc
Headquartered in Houston, Texas and founded in 2011, Nutex Health Inc. is a healthcare management and operations company with two divisions: a Hospital Division and a Population Health Management Division. The Hospital Division owns, develops and operates innovative health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments. This division owns and operates 27 hospital facilities in 12 states. The Population Health Management division owns and operates provider networks such as Independent Physician Associations. Through our Management Services Organization, we provide management, administrative and other support services to our affiliated hospitals and physician groups.
NUTX Free Cash Flow
Nutex Health Inc generated $245.60M in trailing twelve-month free cash flow, representing an FCF yield of 25.25%. This strong FCF yield suggests the company generates substantial cash relative to its market value.
NUTX Shares Outstanding
Nutex Health Inc has 0.01 billion shares outstanding at a share price of $139.57, giving it a market capitalization of $972.57M.